2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
cardiovascular disease cholesterol, LDL-cholesterol diabetes mellitus drug therapy hydroxymethylglutaryl-CoA reductase inhibitors/statins hypercholesterolemia lipids patient compliance primary prevention risk assessment risk reduction discussion risk treatment discussion, secondary prevention ezetimibe proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Circulation
- Topic
- Lipoproteins and Cardiovascular Health
- Field
- Medicine
- Canadian institutions
- —
- Funders
- Center for Innovations in Quality, Effectiveness and SafetyUniversity of California, San FranciscoUniversity of North Carolina at Chapel HillPublic Health Agency of CanadaU.S. Department of Veterans AffairsRush UniversityUniversity of PittsburghOffice of ScienceJohns Hopkins UniversityAmerican Pharmacists AssociationNorthwestern UniversityEmory UniversityTemple UniversityAmerican Diabetes AssociationAmerican Heart AssociationUniversity of Miami
- Keywords
- MedicineGuidelineClinical PracticeTask forceInternal medicineFamily medicinePathologyPolitical sciencePublic administration
- Has abstract in OpenAlex
- yes